Molecular Templates to Present at the Cowen and Company 38th Annual Health Care Conference

Molecular Templates to Present at the Cowen and Company 38th Annual Health Care Conference

AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that its management will provide a corporate overview at the Cowen and Company 38th Annual Health Care Conference, taking place March 12-14 at the Boston Marriott Copley Place in Boston, MA.

Presentation Details 
Date:Tuesday, March 13
Time:11:20am Eastern Time
Location:The Boston Marriott Copley Place
Webcast:http://wsw.com/webcast/cowen46/mtem/
  

About Molecular Templates  

Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com.

Investor Contact:
Andrew McDonald, Ph.D.
[email protected]
646-597-6987

Adam Cutler
Chief Financial Officer
[email protected]
862-204-4006